Burt A Adelman - Net Worth and Insider Trading
Burt A Adelman Net Worth
The estimated net worth of Burt A Adelman is at least $6 Million dollars as of 2024-12-27. Burt A Adelman is the Director of Verve Therapeutics Inc and owns about 428,326 shares of Verve Therapeutics Inc (VERV) stock worth over $3 Million. Burt A Adelman is the EVP, Portfolio Strategy of Biogen Inc and owns about 12,769 shares of Biogen Inc (BIIB) stock worth over $2 Million. Burt A Adelman is also the CMO & EVP, R&D of Dyax Corp and owns about 28,125 shares of Dyax Corp (DYAX) stock worth over $1 Million. Details can be seen in Burt A Adelman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Burt A Adelman has not made any transactions after 2022-05-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Burt A Adelman
Burt A Adelman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Burt A Adelman owns 4 companies in total, including Astria Therapeutics Inc (ATXS) , Dyax Corp (DYAX) , and Biogen Inc (BIIB) among others .
Click here to see the complete history of Burt A Adelman’s form 4 insider trades.
Insider Ownership Summary of Burt A Adelman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATXS | Astria Therapeutics Inc | 2016-04-05 | director |
| DYAX | Dyax Corp | 2016-01-22 | CMO & EVP & R&D |
| BIIB | Biogen Inc | 2007-10-15 | EVP & Development |
 | | 2022-05-12 | director & 10 percent owner |
Burt A Adelman Latest Holdings Summary
Burt A Adelman currently owns a total of 3 stocks. Among these stocks, Burt A Adelman owns 428,326 shares of Verve Therapeutics Inc (VERV) as of May 12, 2022, with a value of $3 Million and a weighting of 47.4%. Burt A Adelman owns 12,769 shares of Biogen Inc (BIIB) as of October 15, 2007, with a value of $2 Million and a weighting of 33.62%. Burt A Adelman also owns 28,125 shares of Dyax Corp (DYAX) as of March 5, 2015, with a value of $1 Million and a weighting of 18.98%.
Latest Holdings of Burt A Adelman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VERV | Verve Therapeutics Inc | 2022-05-12 | 428,326 | 6.30 | 2,698,454 |
| BIIB | Biogen Inc | 2007-10-15 | 12,769 | 149.90 | 1,914,073 |
| DYAX | Dyax Corp | 2015-03-05 | 28,125 | 38.41 | 1,080,281 |
Holding Weightings of Burt A Adelman
Burt A Adelman Form 4 Trading Tracker
According to the SEC Form 4 filings, Burt A Adelman has made a total of 3 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Verve Therapeutics Inc is the acquisition of 10,000 shares on May 12, 2022, which cost Burt A Adelman around $121,500.
According to the SEC Form 4 filings, Burt A Adelman has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 60,500 shares on October 15, 2007, which brought Burt A Adelman around $5 Million.
According to the SEC Form 4 filings, Burt A Adelman has made a total of 0 transactions in Dyax Corp (DYAX) over the past 5 years. The most-recent trade in Dyax Corp is the sale of 9,375 shares on March 5, 2015, which brought Burt A Adelman around $146,812.
Insider Trading History of Burt A Adelman
- 1
Burt A Adelman Trading Performance
GuruFocus tracks the stock performance after each of Burt A Adelman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Burt A Adelman is 46.81%. GuruFocus also compares Burt A Adelman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Burt A Adelman within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Burt A Adelman's insider trading performs compared to the benchmark.
Performance of Burt A Adelman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.51 | | | | | |
| Relative Return to S&P 500(%) | 1.36 | | | | | |
Burt A Adelman Ownership Network
Burt A Adelman Owned Company Details
What does Astria Therapeutics Inc do?
Who are the key executives at Astria Therapeutics Inc?
Burt A Adelman is the director of Astria Therapeutics Inc. Other key executives at Astria Therapeutics Inc include Chief Medical Officer Christopher Morabito , director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Business Officer Andrea Matthews .
Astria Therapeutics Inc (ATXS) Insider Trades Summary
Over the past 18 months, Burt A Adelman made no insider transaction in Astria Therapeutics Inc (ATXS). Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net purchase of 4,295,958 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .
In summary, during the past 3 months, insiders sold 0 shares of Astria Therapeutics Inc (ATXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 4,295,958 shares were bought by its insiders, resulting in a net purchase of 4,275,958 shares.
Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Astria Therapeutics Inc Insider Transactions
Burt A Adelman Mailing Address
Above is the net worth, insider trading, and ownership report for Burt A Adelman. You might contact Burt A Adelman via mailing address: Dyax Corp., 55 Network Drive, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
